Navigation Links
New hereditary breast cancer gene discovered

A new hereditary breast cancer gene has been discovered by scientists at the Lundberg Laboratory for Cancer Research and the Plastic Surgery Clinic at the Sahlgrenska Academy in Sweden. The researchers found that women with a certain hereditary deformity syndrome run a nearly twenty times higher risk of contracting breast cancer than expected.

Several research teams around the world have long been searching for new hereditary breast cancer genes, but thus far few have been found.

"Our findings are extremely important, providing new knowledge of hereditary cancer genes and how they can cause breast cancer. The discovery also makes it possible to uncover breast cancer in women who have a predisposition for Saethre-Chotzen malformation syndrome," says Göran Stenman.

By detailed mapping of families with Saethre-Chotzen syndrome, the Göteborg scientists have now found that women with this syndrome have an elevated risk of contracting breast cancer. Saethre-Chotzen is a syndrome that primarily involves malformations of the skull, face, hands, and feet. The syndrome is caused by mutations in a gene called TWIST1.

"Our findings show that women with this syndrome run a nearly twenty times greater risk of contracting breast cancer than expected. Moreover, many of the women were young when they were affected by breast cancer," says Göran Stenman.

The findings of the study show that women with this syndrome should be receive early mammograms in order to discover breast cancer at an early stage.

"We have already started to use this new knowledge in our work with patients and now recommend regular mammograms for young women with this syndrome. Several early cases of breast cancer have already been uncovered with mammography," says Pelle Sahlin, chief physician at the Plastic Surgery Clinic.

The scientists are now going to perform various experiments to chart the mechanism of how TWIST1 increases the risk of breast cancer. Studies are also under way to find out what proportion of cases of hereditary breast cancer are caused by mutations in the TWIST1 gene.
'"/>

Source:Swedish Research Council


Related biology news :

1. UF scientists test improved gene therapy method for hereditary heart conditions
2. Gene therapy for hereditary lung disease advances
3. Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors
4. Viral DNA sequence a possible trigger for breast cancer
5. Used in a new way, RNA interference permanently silences key breast cancer gene
6. Biomarkers isolated from saliva successfully predict oral and breast cancer
7. Study reveals dramatic difference between breast cancers in US and Africa
8. Compounds in plastic packaging act as environmental estrogens altering breast genes
9. Alcohol consumption disrupts breastfeeding hormones
10. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
11. Scientists discover genetic pathway responsible for breast cancer cell growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... ... Boston-based Laboratory as a Service (LaaS) leader, Mass Innovation Labs, has changed its ... and service offerings for biotech and life sciences companies. , “Meeting the ... agile and adaptable than ever before. One that doubles-down on the things that matter ...
(Date:1/10/2019)... Va. (PRWEB) , ... January 09, 2019 , ... Dr. ... Ottawa Heart Institute in Ottawa, Ontario, Canada. He is also Director of its ... Department of Medicine, in the Department of Radiology, and in the Department of Cellular ...
(Date:1/8/2019)... ... ... Join industry experts Julie Peacock, Client Services at Comprehend and Heather Davis, Independent Consultant ... at 1pm EST. , This webinar will dive into best practices for the ... also present a case study of a leading pharmaceutical company that faced multiple challenges ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today announced ... candidate, code-named "KM-819." KM-819 is an orally active small molecule that is ... Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the leader in microbial ... Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following their selection as ... Annual Meeting brings together leaders of global society–the heads and members of more ...
(Date:1/4/2019)... ... 2019 , ... Calidi Biotherapeutics, Inc., a clinical-stage ... the founding of a scientific and medical advisory board (SMAB). The SMAB will ... the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include Lisa H. ...
(Date:12/19/2018)... VEGAS (PRWEB) , ... December 19, 2018 , ... ... aesthetics procedures at its first rate Stem Cell Training Course in Las Vegas. ... and women. As regenerative procedures explode in popularity nationwide for aesthetics, having the ...
Breaking Biology Technology: